SE9402531L - Sårläkningsmedel - Google Patents

Sårläkningsmedel

Info

Publication number
SE9402531L
SE9402531L SE9402531A SE9402531A SE9402531L SE 9402531 L SE9402531 L SE 9402531L SE 9402531 A SE9402531 A SE 9402531A SE 9402531 A SE9402531 A SE 9402531A SE 9402531 L SE9402531 L SE 9402531L
Authority
SE
Sweden
Prior art keywords
pct
chitosan
polysaccharide
composition
wound healing
Prior art date
Application number
SE9402531A
Other languages
English (en)
Swedish (sv)
Other versions
SE9402531D0 (sv
Inventor
Olle Larm
Ibrahim Gouda
Original Assignee
Medicarb Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medicarb Ab filed Critical Medicarb Ab
Priority to SE9402531A priority Critical patent/SE9402531L/xx
Publication of SE9402531D0 publication Critical patent/SE9402531D0/xx
Priority to JP50496696A priority patent/JP3337472B2/ja
Priority to DE69523585T priority patent/DE69523585T2/de
Priority to US08/765,353 priority patent/US5902798A/en
Priority to CA002194976A priority patent/CA2194976C/en
Priority to AU30902/95A priority patent/AU691322B2/en
Priority to AT95926574T priority patent/ATE207753T1/de
Priority to DK95926574T priority patent/DK0759760T3/da
Priority to EP95926574A priority patent/EP0759760B1/de
Priority to ES95926574T priority patent/ES2161903T3/es
Priority to PCT/SE1995/000875 priority patent/WO1996002260A1/en
Publication of SE9402531L publication Critical patent/SE9402531L/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
SE9402531A 1994-07-19 1994-07-19 Sårläkningsmedel SE9402531L (sv)

Priority Applications (11)

Application Number Priority Date Filing Date Title
SE9402531A SE9402531L (sv) 1994-07-19 1994-07-19 Sårläkningsmedel
PCT/SE1995/000875 WO1996002260A1 (en) 1994-07-19 1995-07-18 Wound healing agent
CA002194976A CA2194976C (en) 1994-07-19 1995-07-18 Wound healing agent
DE69523585T DE69523585T2 (de) 1994-07-19 1995-07-18 Wundheilmittel
US08/765,353 US5902798A (en) 1994-07-19 1995-07-18 Method of promoting dermal wound healing with chitosan and heparin or heparin sulfate
JP50496696A JP3337472B2 (ja) 1994-07-19 1995-07-18 創傷治癒剤
AU30902/95A AU691322B2 (en) 1994-07-19 1995-07-18 Wound healing agent
AT95926574T ATE207753T1 (de) 1994-07-19 1995-07-18 Wundheilmittel
DK95926574T DK0759760T3 (da) 1994-07-19 1995-07-18 Sårhelingsmiddel
EP95926574A EP0759760B1 (de) 1994-07-19 1995-07-18 Wundheilmittel
ES95926574T ES2161903T3 (es) 1994-07-19 1995-07-18 Agente para curar heridas.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9402531A SE9402531L (sv) 1994-07-19 1994-07-19 Sårläkningsmedel

Publications (2)

Publication Number Publication Date
SE9402531D0 SE9402531D0 (sv) 1994-07-19
SE9402531L true SE9402531L (sv) 1996-01-20

Family

ID=20394771

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9402531A SE9402531L (sv) 1994-07-19 1994-07-19 Sårläkningsmedel

Country Status (11)

Country Link
US (1) US5902798A (de)
EP (1) EP0759760B1 (de)
JP (1) JP3337472B2 (de)
AT (1) ATE207753T1 (de)
AU (1) AU691322B2 (de)
CA (1) CA2194976C (de)
DE (1) DE69523585T2 (de)
DK (1) DK0759760T3 (de)
ES (1) ES2161903T3 (de)
SE (1) SE9402531L (de)
WO (1) WO1996002260A1 (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5576839A (en) * 1991-09-25 1996-11-19 Minolta Camera Kabushiki Kaisha Camera system including a separatable recorder
SE508760C2 (sv) * 1997-04-29 1998-11-02 Medicarb Ab Användning av en komposition innefattande kitosan i kombination med en polysackarid, som aktiv komponent i ett lösningsmedel, för framställning av ett spendoppningsmedel för mjölkproducerande djur
NL1011680C2 (nl) 1999-03-26 2000-09-27 Nutricia Nv Voedingssamenstellen die licht negatief geladen, niet-verteerbare polysacchariden bevatten en gebruik ervan voor het verminderen van transport door tight junctions.
US6391334B1 (en) 1999-10-25 2002-05-21 Amway Corporation Barrier-forming composition
ES2491866T3 (es) * 1999-11-15 2014-09-08 Piramal Healthcare (Canada) Limited Disolución biopolimérica acuosa autogelificante controlada por la temperatura y dependiente del pH
US20030158302A1 (en) * 1999-12-09 2003-08-21 Cyric Chaput Mineral-polymer hybrid composition
ATE243049T1 (de) * 1999-12-09 2003-07-15 Biosyntech Canada Inc Mineral-polymer hybrid-zusammensetzung
GB9929472D0 (en) * 1999-12-13 2000-02-09 Btg Int Ltd Polymeric film
DK1294414T3 (da) * 2000-06-29 2006-07-24 Biosyntech Canada Inc Præparat og fremgangsmåde til heling og regenerering af brusk og andre væv
US20040091540A1 (en) * 2000-11-15 2004-05-13 Desrosiers Eric Andre Method for restoring a damaged or degenerated intervertebral disc
US6623761B2 (en) 2000-12-22 2003-09-23 Hassan Emadeldin M. Method of making nanoparticles of substantially water insoluble materials
KR20020066024A (ko) * 2001-02-08 2002-08-14 굿젠 주식회사 수용성 키토산과 헤파린으로 이루어진 상처 치유 촉진연고 조성물과 필름 및 제품
WO2002083104A1 (en) * 2001-04-12 2002-10-24 Medicarb Ab An effervescent solid composition of matter
SE522529C2 (sv) 2001-04-12 2004-02-17 Medicarb Ab Effervescent fastämneskomposition innefattande som aktiv komponent kitosan, dess derivat och salter därav, användning samt framställning därav
US7297343B2 (en) * 2001-07-31 2007-11-20 Biosurface Engineering Technologies, Inc. Bioactive medical films
KR20020060627A (ko) * 2002-01-16 2002-07-18 조석형 키토산/음이온성 다당류의 창상 치유제
WO2003070749A2 (en) 2002-02-15 2003-08-28 Northwestern University Self-assembly of peptide-amphiphile nanofibers under physiological conditions
CA2493083C (en) * 2002-07-16 2012-11-06 Bio Syntech Canada Inc. Composition for cytocompatible, injectable, self-gelling chitosan solutions for encapsulating and delivering live cells or biologically active factors
US7554021B2 (en) 2002-11-12 2009-06-30 Northwestern University Composition and method for self-assembly and mineralization of peptide amphiphiles
US20070053848A1 (en) * 2003-08-26 2007-03-08 Stockel Richard F Antimicrobial materials for dental care applications
JP2006347883A (ja) * 2003-09-08 2006-12-28 Neetec:Kk 糖鎖含有キトサン誘導体及びグリコサミノグリカンを含有する医療用組成物
CN102225964A (zh) 2003-12-05 2011-10-26 西北大学 自组装的肽两亲物和用于生长因子传递的相关方法
US20070086977A1 (en) * 2003-12-22 2007-04-19 Stockel Richard F Method of treating dermatological conditions
US20050136024A1 (en) * 2003-12-22 2005-06-23 Stockel Richard F. Dermatological compositions
US20050283004A1 (en) * 2004-06-18 2005-12-22 Hopax Chemicals Manufacturing Co., Ltd. Alkylsulfonated polyaminosaccharides
KR20070108555A (ko) * 2005-03-04 2007-11-12 노오쓰웨스턴 유니버시티 혈관신생 헤파린 결합 펩티드 양친매성 화합물
WO2007051311A1 (en) * 2005-11-04 2007-05-10 Bio Syntech Canada Inc. Gel formation of polyelectrolyte aqueous solutions by thermally induced changes in ionization state
DE102006020035A1 (de) * 2006-04-26 2007-10-31 B. Braun Melsungen Ag Herstellung und Verwendung von Poly(hydroxyethylstärke)chitin- und Poly(Carboxymethylstärke)chitin-Verbindungen
EP1958613A1 (de) * 2007-02-15 2008-08-20 Polichem S.A. Dermale filmbildende flüssige Formulierungen zur Wirkstofffreisetzung auf der Haut
US8076295B2 (en) 2007-04-17 2011-12-13 Nanotope, Inc. Peptide amphiphiles having improved solubility and methods of using same
WO2009028965A1 (en) 2007-08-28 2009-03-05 Theodore Athanasiadis Surgical hydrogel
ES2650937T3 (es) * 2008-11-20 2018-01-23 Laboratori Derivati Organici S.P.A. Composiciones dermatológicas que comprenden sulfato de heparano
BRPI0920896B8 (pt) * 2008-12-06 2021-05-25 Braun Melsungen Ag composto de fórmula geral (i) (t-z)n-p (i), formulação farmacêutica e processo para preparar um composto de fórmula geral (i)
CN102365099A (zh) 2009-03-31 2012-02-29 B·布朗·梅尔松根有限公司 胺化多糖粘合制品
KR20120012811A (ko) 2009-04-13 2012-02-10 노오쓰웨스턴 유니버시티 신규한 연골 재생용 펩티드-기반 스카폴드 및 이들의 사용 방법
CA2763092A1 (en) * 2009-06-10 2010-12-16 Exthera Ab Use of a composition for the treatment of mucositis
WO2011026498A1 (en) 2009-09-01 2011-03-10 Medovent Gmbh Chitosan tissue dressing
US9629856B2 (en) 2010-03-03 2017-04-25 Anteis Sa Compositions and methods for the treatment of skin diseases and disorders using antimicrobial peptide sequestering compounds
EP3034085B1 (de) 2013-08-13 2019-10-23 Seikagaku Corporation Arzneimittel mit kationisiertem chitosan
US9192574B2 (en) 2013-10-24 2015-11-24 Medtronic Xomed, Inc. Chitosan paste wound dressing
US9192692B2 (en) 2013-10-24 2015-11-24 Medtronic Xomed, Inc. Chitosan stenting paste
FR3016882A1 (fr) 2014-01-30 2015-07-31 Sofradim Production Procede de preparation de chitosane a haut degre d’acetylation
US10126298B2 (en) 2015-05-04 2018-11-13 Arman Nabatian Hydrogels containing embedded substrates for targeted binding of molecules
US9248160B1 (en) * 2015-07-28 2016-02-02 Zo Skin Health, Inc. Post-procedure skin care systems, compositions, and methods of use thereof
KR20200108020A (ko) 2018-01-12 2020-09-16 보스톤 싸이엔티픽 싸이메드 인코포레이티드 지혈을 달성하기 위한 분말
WO2019211483A1 (en) 2018-05-04 2019-11-07 Bonoss Medical Aktiebolag A composition for reduction of scar formation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4378017A (en) * 1980-03-21 1983-03-29 Kureha Kagaku Kogyo Kabushiki Kaisha Composite material of de-N-acetylated chitin and fibrous collagen
US4326532A (en) * 1980-10-06 1982-04-27 Minnesota Mining And Manufacturing Company Antithrombogenic articles
US4532134A (en) * 1981-04-06 1985-07-30 Malette William Graham Method of achieving hemostasis, inhibiting fibroplasia, and promoting tissue regeneration in a tissue wound
US5002582A (en) * 1982-09-29 1991-03-26 Bio-Metric Systems, Inc. Preparation of polymeric surfaces via covalently attaching polymers
CA1202904A (en) * 1983-11-21 1986-04-08 Brian G. Sparkes Chitosan based wound dressing materials
JPS61253065A (ja) * 1985-05-02 1986-11-10 片倉チツカリン株式会社 キトサン誘導体およびコラ−ゲンの複合材の医用材料およびその製造法
US4879282A (en) * 1987-03-17 1989-11-07 Saliba Jr Michael J Medical application for heparin and related molecules
US5037810A (en) * 1987-03-17 1991-08-06 Saliba Jr Michael J Medical application for heparin and related molecules
DE4200080A1 (de) * 1992-01-03 1993-09-30 Reinmueller Johannes Pharmazeutische Zusammensetzung zur Wund-, Narben- und Keloidbehandlung
JP3205104B2 (ja) * 1992-01-20 2001-09-04 川研ファインケミカル株式会社 化粧料
SE9402529D0 (sv) * 1994-07-19 1994-07-19 Astra Ab Anti-adherensmedel

Also Published As

Publication number Publication date
US5902798A (en) 1999-05-11
ES2161903T3 (es) 2001-12-16
JP3337472B2 (ja) 2002-10-21
EP0759760A1 (de) 1997-03-05
ATE207753T1 (de) 2001-11-15
SE9402531D0 (sv) 1994-07-19
AU3090295A (en) 1996-02-16
CA2194976A1 (en) 1996-02-01
WO1996002260A1 (en) 1996-02-01
CA2194976C (en) 2002-04-30
DE69523585D1 (de) 2001-12-06
JPH10502665A (ja) 1998-03-10
DE69523585T2 (de) 2002-04-11
DK0759760T3 (da) 2001-11-26
EP0759760B1 (de) 2001-10-31
AU691322B2 (en) 1998-05-14

Similar Documents

Publication Publication Date Title
SE9402531D0 (sv) Sårläkningsmedel
US5929050A (en) Chondroitin sulfate composition and method for wound treatment
KR970704459A (ko) 경조직 자극제(Hard Tissue Stimulating Agent)
AR003439A1 (es) Composicion de polisacaridos injertados con antioxidante y metodo para su preparacion.
NO20035569D0 (no) Sårbandasje og metode for kontroll av livstruende bl degree dning
BR0304601A (pt) Curativo de ferimento hemostático contendo polissacarìdeos modificados por aldeìdo
DE69702911T2 (de) Oxydierte oligosaccharide
NZ290218A (en) Composition to reduce adhesion in wound healing
RU97102350A (ru) Анти-адгезионный агент
CA2070685A1 (en) Method for treating painful, inflammatory or allergic disorders
EE04953B1 (et) Tsinkhaluronaadi kasutamine ja meetod ravimkoostise valmistamiseks
DK0921806T3 (da) Mannose-6-phosphat-præparat og anvendelse deraf til behandling af fibrøse lidelser
DE69705110T2 (de) Topische pharmazeutische zusammensetzungen, welche heparin enthalten
BR9407669A (pt) Bandagem de ferida que compreende alginato
EA199800819A1 (ru) Способ лечения биполярного расстройства
FI963785A (fi) Hypokolesteroleemisia, antiateroskleroottisia ja hypotriglyserideemisiä merkaptoasetyyliamidijohdannaisia
ATE202922T1 (de) Ophthalmische cromolyn-gelzubereitung

Legal Events

Date Code Title Description
NAV Patent application has lapsed